Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis∗∗Previously presented at the Chicago Dermatological Society meeting, Chicago, Ill, November 13, 2002 Linda C. Wang, MD, JD, Maria M. Medenica, MD, Christopher R. Shea, MD, Shail Busbey, MD Journal of the American Academy of Dermatology Volume 49, Issue 1, Pages 157-158 (July 2003) DOI: 10.1067/mjd.2003.574 Copyright © 2003 American Academy of Dermatology, Inc Terms and Conditions
Fig. 1 Biopsy specimen taken from the left shin revealed parakeratosis, spongiosis, and capillaritis. (Hematoxylin-eosin stain; original magnification ×40.) Journal of the American Academy of Dermatology 2003 49, 157-158DOI: (10.1067/mjd.2003.574) Copyright © 2003 American Academy of Dermatology, Inc Terms and Conditions
Fig. 2 Lesions of eczematid-like purpura of Doucas and Kapetenakis 53 days after infusion of infliximab for Crohn's disease. Journal of the American Academy of Dermatology 2003 49, 157-158DOI: (10.1067/mjd.2003.574) Copyright © 2003 American Academy of Dermatology, Inc Terms and Conditions